Infertility Clinical Trial
Official title:
The Relationship Between Personality Traits and Perioperative Anesthetic Drug Consumption
Verified date | April 2024 |
Source | Ondokuz Mayis University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
In this study, we aimed to examine the association between personality traits and amount of anesthetic drug consumption,of the patients who will receive sedoanalgesia for the oocyte retrieval procedure. As well as determining the anxiety scores in the preoperative period, the time to reach the desired sedation level, hemodynamic parameters in the perioperative period, peripheral oxygen saturation, EtCO2 value, postoperative pain, postanesthetic recovery, analgesic drug need, unconscious movement, and patient satisfaction.
Status | Active, not recruiting |
Enrollment | 90 |
Est. completion date | July 30, 2024 |
Est. primary completion date | March 30, 2024 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 50 Years |
Eligibility | Inclusion Criteria: - 18- 50 year-old elective patients who signed the informed consent form from ASA I-II patients scheduled for oocyte retrieval. - Patients with sufficient education and mental capacity to complete in assessment scales and questionnaires. - Patients without neurological disorders, psychological illnesses, or drug or alcohol abuse - Patients without stimulant drug and alcohol consumption - Absence of significant cardiovascular, respiratory, kidney or liver disease. Exclusion Criteria: - Psychiatric or neurological disorder - Psychiatric drug use or alcohol consumption - Pregnancy - Presence of severe cardiac, hepatic or cerebrovascular disease - History of allergy to local anesthetics or systemic opioids - History of chronic pain - Patients who are unable to evaluate scales and questionnaires |
Country | Name | City | State |
---|---|---|---|
Turkey | Ondokuz Mayis University | Samsun | Atakum |
Lead Sponsor | Collaborator |
---|---|
Ondokuz Mayis University |
Turkey,
CLARIDGE GS, HERRINGTON RN. Sedation threshold, personality, and the theory of neurosis. J Ment Sci. 1960 Oct;106:1568-83. doi: 10.1192/bjp.106.445.1568. No abstract available. — View Citation
Lee SS, Kim HH, Park HJ. Are Histrionic Personality Traits Associated with Irritability during Conscious Sedation Endoscopy? Gastroenterol Res Pract. 2015;2015:702492. doi: 10.1155/2015/702492. Epub 2015 Apr 12. — View Citation
Maranets I, Kain ZN. Preoperative anxiety and intraoperative anesthetic requirements. Anesth Analg. 1999 Dec;89(6):1346-51. doi: 10.1097/00000539-199912000-00003. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Propofol consumption | mg, from the beginning to the end of the transvaginal oocyte retrieval procedure | from the beginning to the end of the transvaginal oocyte retrieval procedure) | |
Secondary | Time until the Ramsey Sedation Score of 4 is reached | The period elapsed after the patient is transported to the operating table and the sedation protocol begins. | -The period of time starting with the propofol injection until the Ramsey Sedation Score of 4 | |
Secondary | Amount of propofol (mg) used until the required sedation depth is reached | The amount of iv propofol administered until the Ramsey Sedation Score of 4 is obtained | The period of time starting with the propofol injection until the Ramsey Sedation Score of 4 | |
Secondary | Systolic, diastolic and, mean Blood pressure (mm/Hg) | It will be monitored and documented every 5 minutes during the procedure. | every 5 minutes during the procedure | |
Secondary | Heart rate (beats/min) | It will be monitored and documented every 5 minutes during the procedure. | every 5 minutes during the procedure. | |
Secondary | Peripheral oxygen saturation (%) | (%): It will be monitored and documented every 5 minutes during the procedure. | every 5 minutes during the procedure | |
Secondary | Number of Involuntary movement during the procedure | The presence of involuntary movement will be documented during the procedure. | during the procedure. | |
Secondary | Postoperative pain (visual analog scale) | Pain status will be evaluated based on visual analog scale (VAS) at rest and after movement.every 30-minute intervals for one hour in the recovery room. Each VAS is scores 0-10 (0=no pain, 10=unbearable pain) | After the procedure,every 30 minutes up to 1 hour | |
Secondary | Analgesic consumption | The analgesic agents administered to the patients throughout the postoperative period will be documented. | postoperatively up to 2 hours | |
Secondary | Postoperative recovery time | The time until the Modified Aldrete Score reaches 9 points will be determined. | postoperatively up to 2 hours | |
Secondary | The incidences of post-operative nausea and vomiting (PONV) | the presence of nausea and vomiting will be recorded for 24 hours after procedure | the time from the end of the procedure until discharge | |
Secondary | Undesirable events and interventions | Bradycardia, hypotension, airway obstruction, hypoxia will be documented throughout the perioperative phase with the intervention. | time between start of procedure and discharge |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03607409 -
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
|
||
Recruiting |
NCT02312076 -
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
|
Phase 4 | |
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Completed |
NCT03287479 -
Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®)
|
N/A | |
Terminated |
NCT03522350 -
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
|
N/A | |
Completed |
NCT04496284 -
Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
|
N/A | |
Completed |
NCT03623659 -
pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts
|
N/A | |
Completed |
NCT03895099 -
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors
|
Phase 3 | |
Active, not recruiting |
NCT04142112 -
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
|
N/A | |
Completed |
NCT03152643 -
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer
|
N/A | |
Recruiting |
NCT03683771 -
Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
|
||
Recruiting |
NCT03161119 -
Comparing Two Different Embryo Transfer Catheters
|
N/A | |
Completed |
NCT04108039 -
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
|
N/A | |
Completed |
NCT03678584 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)
|
N/A | |
Completed |
NCT03678610 -
Handling Medium for ICSI With Ionomycin and Latrunculin A
|
N/A | |
Completed |
NCT03678818 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)
|
N/A | |
Completed |
NCT03678571 -
Oocyte Vitrification Aided With Latrunculin A
|
N/A | |
Completed |
NCT03677492 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD)
|
N/A | |
Completed |
NCT03678597 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB)
|
N/A | |
Completed |
NCT03678558 -
Oocyte Vitrification Aided With Cytochalasin B
|
N/A |